| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥40.75B | +16.4% |
| Gross profit | ¥3.48B | — |
| Operating income | ¥1.09B | — |
| Net income | ¥1.07B | +27.5% |
| Gross margin | 8.5% | Net margin 2.6% |
| Revenue Q/Q | -4.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥37.27B | 91.5% |
| R&D | ¥1.65B | 4.1% |
| SG&A | ¥0.87B | 2.1% |
| Tax & other | ¥0.02B | 0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
今世缘 ・ 万泰生物 ・ 豪威集团 ・ 华友钴业 ・ 瑞芯微 ・ 兆易创新 ・ 洛阳钼业 ・ 德业股份 ・ 东鹏饮料 ・ 澜起科技 ・ 中国通号 ・ 中微公司
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies